Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2000
06/28/2000EP1013766A2 Peptides for the detection of HIV-1-Group O
06/28/2000EP1013761A2 Humanized chimeric antibody directed against ganglioside GD3
06/28/2000EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same
06/28/2000EP1013758A2 Novel carbonyl reductase, method for producing said enzyme, DNA encoding said enzyme, and method for producing alcohol using said enzyme
06/28/2000EP1013757A2 Attenuated forms of bovine viral diarrhea virus
06/28/2000EP1013668A1 Monoclonal antibody against human monocytes
06/28/2000EP1013666A2 Methods for obtaining a p53/p90 complex
06/28/2000EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
06/28/2000EP1013285A2 Urokinase-type plasminogen activator receptor
06/28/2000EP1012334A1 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
06/28/2000EP1012321A2 Viral infection of cells using viral vectors
06/28/2000EP1012319A2 Insect expression vectors
06/28/2000EP1012318A2 Synthetic hybrid plant promoter
06/28/2000EP1012316A1 Rank1, an ankyrin-repeat containing peptide from rice associated with disease resistance
06/28/2000EP1012310A1 Fusion proteins comprising coiled-coil structures
06/28/2000EP1012309A2 Chimeric polypeptides containing chemokine domains
06/28/2000EP1012308A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
06/28/2000EP1012306A2 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use
06/28/2000EP1012303A1 Factor x deletion mutants and analogues thereof
06/28/2000EP1012302A1 Human nucleotide pyrophosphohydrolase
06/28/2000EP1012296A2 Mammalian thioredoxin
06/28/2000EP1012295A1 Alphavirus rna replicon systems
06/28/2000EP1012294A2 Microbial genes for secreted beta-glucuronidases, gene products and uses thereof
06/28/2000EP1012293A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
06/28/2000EP1012292A1 Ntn-2 member of tnf ligand family
06/28/2000EP1012291A1 Multiple site delivery of adenoviral vector for the induction of angiogenesis
06/28/2000EP1012288A1 Novel human cystatin-like protein
06/28/2000EP1012286A2 Allelic variant of human stat3
06/28/2000EP1012284A1 Mpl ligand analogs
06/28/2000EP1012283A1 Mage-3 peptides presented by hla class ii molecules
06/28/2000EP1012281A2 Human leukocyte calcium activated potassium channel polypeptide
06/28/2000EP1012279A1 Mitofusin genes and their uses
06/28/2000EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them
06/28/2000EP1012274A1 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap02-l)
06/28/2000EP1012273A2 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012272A1 Human apoptosis-associated protein; encoding dna is similar to p53 response mouse gene ei124
06/28/2000EP1012270A2 Kay - a novel immune system protein
06/28/2000EP1012268A1 Ires sequences with high translational efficiency and expression vectors containing the sequence
06/28/2000EP1012263A1 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012262A1 Human frezzled-like protein
06/28/2000EP1012261A1 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012260A1 Interleukin-20
06/28/2000EP1012251A1 Protease variants and compositions
06/28/2000EP1012250A1 Regulation of gene expression in plants
06/28/2000EP1012243A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes
06/28/2000EP1012242A1 Human sigma receptor
06/28/2000EP1012241A1 Screening assays for g protein coupled receptor agonists and antagonists
06/28/2000EP1012240A2 Cancer immunotherapy with semi-allogeneic cells
06/28/2000EP1012239A1 Method and system for managing immunocompetent cell batches for delayed use
06/28/2000EP1012238A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl
06/28/2000EP1012237A1 Methods and compositions for producing plants and microorganisms that express feedback insensitive threonine dehydratase/deaminase
06/28/2000EP1012236A1 Retrovirus and viral vectors
06/28/2000EP1012235A1 Improved vanillin production
06/28/2000EP1012234A1 Dry powder cells and cell culture reagents and methods of production thereof
06/28/2000EP1012231A1 Dna molecules encoding ctenocephalides felis glutamate gated chloride channels
06/28/2000EP1012229A1 Regulators of ucp2 gene expression
06/28/2000EP1012190A1 Eosinophil eotaxin receptor
06/28/2000EP1012177A1 Estrogen receptor
06/28/2000EP1012176A1 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens
06/28/2000EP1012174A1 Nik proteins, nucleic acids and methods
06/28/2000EP1012173A1 Isolated nona- and decapeptides which bind to hla molecules, and the use thereof
06/28/2000EP1012160A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides
06/28/2000EP1012158A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase
06/28/2000EP1012155A1 Human uncoupling protein 3
06/28/2000EP1011732A1 Lineage-restricted neuronal precursors
06/28/2000EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/28/2000EP1011717A1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
06/28/2000EP1011703A1 Nucleosome-based anti-tumor compositions
06/28/2000EP1011699A1 Galactosidase modified submucosal tissue
06/28/2000EP1011698A1 Chemical supplementation of bone
06/28/2000EP1011697A1 Targeted system for removing tumor cells from cell populations
06/28/2000EP1011694A2 Conditioning for allogeneic stem cell transplantation
06/28/2000EP1011518A1 Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method for preparation thereof
06/28/2000EP1011330A1 Central nervous system axon regeneration
06/28/2000EP1011328A1 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity
06/28/2000EP1011320A1 Transplacental delivery of oligonucleotides
06/28/2000EP0866719B1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product
06/28/2000EP0639224B1 Lectin domain variants of selectin
06/28/2000EP0557418B1 A beta-type transforming growth factor
06/28/2000CN1258318A Selection marker
06/28/2000CN1258316A Plant transformation methods
06/28/2000CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition
06/27/2000US6080915 Constructs encoding degradation enzymes for aromatic compounds and transgenic plants containing same
06/27/2000US6080912 Methods for creating transgenic animals
06/27/2000US6080841 Human induced tumor protein
06/27/2000US6080729 Polypeptides and polynucleotides used to screen for antibacterial compounds
06/27/2000US6080579 Method for producing human intervertebral disc cells
06/27/2000US6080578 Cytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasia
06/27/2000US6080577 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy
06/27/2000US6080575 Isolated nucleic acid construct for expressing a biologically active substance which is activated by an enzyme released from mammalian cells; for target cell-specific therapy for tumors and inflammation
06/27/2000US6080571 Highly efficient production and isolation of viral particles utilizing tentacle anion exchange
06/27/2000US6080569 Adenovirus vectors generated from helper viruses and helper-dependent vectors
06/27/2000US6080558 Polynucleotide encoding human growth regulator protein
06/27/2000US6080542 Plant peptide transport gene
06/27/2000US6080412 Pharmaceutical microencapsulation
06/27/2000US6080409 Immunostimulatory method
06/27/2000US6080406 Hematopoietic cytokine receptor
06/27/2000US6080405 Foam proteins and use thereof
06/27/2000US6080398 Chemokines modified by truncation of from 2 to 8 amino acids from the amino terminus of the corresponding mature chemokine selected from kc, gro-beta, gro-gamma, and gro-alpha; lower dose needed, less toxicity
06/27/2000CA2198603C Use of stem cell factor and soluble interleukin-6 receptor for the ex vivo expansion of hematopoietic multipotential cells